- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 15.92M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.73M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.49M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.2M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.02M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.37M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.22M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.3M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.23M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.42M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.44M |
| Total Assets restated | Q1 2025 · Mar 31, 2024 | $4.44M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$960K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $175K |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.65M |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.15 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $840K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.03M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$2.02M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $12K |
| Revenue | Q1 2025 · Mar 31, 2024 | $57K |